CHARACTERIZATION OF HUMANIZED ANTI-P185HER2 ANTIBODY FAB FRAGMENTS PRODUCED IN ESCHERICHIA-COLI

被引:0
|
作者
KELLEY, RF
OCONNELL, MP
CARTER, P
PRESTA, L
EIGENBROT, C
COVARRUBIAS, M
SNEDECOR, B
SPECKART, R
BLANK, G
VETTERLEIN, D
KOTTS, C
机构
[1] GENENTECH INC, DEPT FERMENTAT, San Francisco, CA 94080 USA
[2] GENENTECH INC, DEPT PROC SCI, San Francisco, CA 94080 USA
[3] GENENTECH INC, DEPT MED & ANALYT CHEM, San Francisco, CA 94080 USA
来源
ACS SYMPOSIUM SERIES | 1993年 / 526卷
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We have been using biochemical and biophysical methods to characterize chimeric and humanized variants of the murine monoclonal antibody 4D5, directed against human epidermal growth factor receptor 2 (p185HER2). These studies were performed on antibody Fab fragments produced by secretion from E. coli. Humanized Fab fragment (hu4D5-8 Fab) was expressed at very high levels (1-2 g/L), whereas chimeric Fab (ch4D5 Fab) was expressed at much lower titers (5-20 mg/L), as determined by antigen-binding ELISA of supernatants from 10 L fermentations. Hu4D5-8 Fab and ch4D5 Fab purified by using affinity chromatography on immobilized bacterial IgG-binding proteins gave identical far UV-CD spectra characteristic of the immunoglobulin fold. Thermodynamic studies of antigen binding show comparable affinities (DELTAG) for ch and hu4D5-8 Fab, but different DELTAH values suggesting slight differences in the mechanism of binding. This difference is reflected in the anti-proliferative activity of these fragments on human breast tumor cells.
引用
收藏
页码:218 / 239
页数:22
相关论文
共 50 条
  • [1] CHARACTERIZATION OF HUMANIZED ANTI-P185HER2 ANTIBODY-FAB FRAGMENTS PRODUCED IN ESCHERICHIA-COLI
    KELLEY, R
    OCONNELL, M
    CARTER, P
    PRESTA, L
    EIGENBROT, C
    COVARRUBIAS, M
    SNEDECOR, B
    VETTERLEIN, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 58 - BTEC
  • [2] ANTIGEN-BINDING THERMODYNAMICS AND ANTIPROLIFERATIVE EFFECTS OF HUMANIZED ANTI-P185HER2 ANTIBODY FAB FRAGMENTS
    KELLEY, R
    OCONNELL, M
    CARTER, P
    EIGENBROT, C
    PRESTA, L
    FASEB JOURNAL, 1992, 6 (01): : A208 - A208
  • [3] ANTIGEN-BINDING THERMODYNAMICS AND ANTIPROLIFERATIVE EFFECTS OF CHIMERIC AND HUMANIZED ANTI-P185HER2 ANTIBODY FAB FRAGMENTS
    KELLEY, RF
    OCONNELL, MP
    CARTER, P
    PRESTA, L
    EIGENBROT, C
    COVARRUBIAS, M
    SNEDECOR, B
    BOURELL, JH
    VETTERLEIN, D
    BIOCHEMISTRY, 1992, 31 (24) : 5434 - 5441
  • [4] Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging
    Olafsen, T
    Kenanova, VE
    Sundaresan, G
    Anderson, AL
    Crow, D
    Yazaki, PJ
    Li, L
    Press, MF
    Williams, LE
    Wong, JYC
    Raubitschek, AA
    Shively, JE
    Wu, AM
    CANCER RESEARCH, 2005, 65 (13) : 5907 - 5916
  • [5] Differential signaling by an anti-p185HER2 antibody and heregulin
    Le, XF
    Vadlamudi, R
    McWatters, A
    Bae, DS
    Mills, GB
    Kumar, R
    Bast, RC
    CANCER RESEARCH, 2000, 60 (13) : 3522 - 3531
  • [6] HUMANIZATION OF AN ANTI-P185HER2 ANTIBODY FOR HUMAN CANCER-THERAPY
    CARTER, P
    PRESTA, L
    GORMAN, CM
    RIDGWAY, JBB
    HENNER, D
    WONG, WLT
    ROWLAND, AM
    KOTTS, C
    CARVER, ME
    SHEPARD, HM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4285 - 4289
  • [7] RENATURATION, PURIFICATION AND CHARACTERIZATION OF RECOMBINANT FAB-FRAGMENTS PRODUCED IN ESCHERICHIA-COLI
    BUCHNER, J
    RUDOLPH, R
    BIO-TECHNOLOGY, 1991, 9 (02): : 157 - 162
  • [8] EXPRESSION OF FUNCTIONAL ANTIBODY FV AND FAB FRAGMENTS IN ESCHERICHIA-COLI
    PLUCKTHUN, A
    SKERRA, A
    METHODS IN ENZYMOLOGY, 1989, 178 : 497 - 515
  • [9] Development of anti-p185HER2 immunoliposomes for cancer therapy
    Park, J. W.
    Hong, K.
    Carter, P.
    Asgari, H.
    Proceedings of the National Academy of Sciences of the United States of America, 92 (05):
  • [10] CHARACTERIZATION OF AN ANTI-P185HER2 MONOCLONAL-ANTIBODY THAT STIMULATES RECEPTOR FUNCTION AND INHIBITS TUMOR-CELL GROWTH
    SARUP, JC
    JOHNSON, RM
    KING, KL
    FENDLY, BM
    LIPARI, MT
    NAPIER, MA
    ULLRICH, A
    SHEPARD, HM
    GROWTH REGULATION, 1991, 1 (02): : 72 - 82